Determinations were made of fibrin degradation products (FDP) in serum from 19 patients who were receiving radiotherapy after the surgical treatment of malignant ovarian tumours. FDP decreased or disappeared in association with operation and radiotherapy but increased or re-appeared with recurrences. Possible explanations of this phenomenon are discussed.